Bacterin CEO to present at orthopedic conference

Bacterin CEO Dan Goldberger will present at the Canaccord Genuity Musculoskeletal Conference in Las Vegas on March 24.

Advertisement

Bacterin develops, manufactures and markets biologics products to domestic and international markets, which can be used for a number of applications, including spinal fusions and back pain relief.

More articles on devices:

Smith & Nephew shares lost 7.14% last week — 5 key updates
Stryker shares drop 4.94% in 7 days: 5 things to know
Minimus Spine receives U.S. patent — 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.